Procter & Gamble stock (US7427181091): Q4 earnings meet revenue expectations, EPS beats estimates

Procter & Gamble, the consumer goods giant, released its Q4 CY2025 earnings on May 13, 2026, showing revenue of $22.21 billion, a 1.5% increase year on year that matched analyst expectations of $22.29 billion, according to StockStory as of May 13, 2026. Adjusted EPS came in at $1.88, surpassing estimates of $1.86 by 1.2%, though organic revenue was flat and sales volumes dipped 1%.

The stock traded down 1.9% to $143.31 immediately after the report, reflecting investor concerns over volume declines and a miss on adjusted EBITDA of $6.39 billion versus $6.46 billion expected, per the same source. Management reiterated full-year adjusted EPS guidance at $6.96 midpoint.

As of: 13.05.2026

By the editorial team – specialized in equity coverage.

Procter & Gamble: core business model

Procter & Gamble operates as a multinational consumer goods corporation, producing branded products in beauty, grooming, health care, fabric and home care, and baby, feminine, and family care segments. Its portfolio includes household names like Tide, Pampers, Gillette, and Crest, sold in over 180 countries. The company focuses on innovation and brand investment to drive consumer loyalty.

For US investors, Procter & Gamble's NYSE listing and significant exposure to the US market—where it generates a substantial portion of sales—make it a staple in defensive portfolios amid economic uncertainty.

Main revenue and product drivers for Procter & Gamble

Key revenue streams stem from fabric and home care (e.g., Tide, Ariel), which often lead growth, alongside grooming (Gillette) and baby care (Pampers). In Q4 CY2025, revenue grew 1.5% to $22.21 billion, though organic sales were flat due to a 1% volume drop, offset by pricing, as reported by StockStory as of May 13, 2026.

Adjusted EBITDA margin stood at 28.8%, with operating margin at 24.2%, down from 27.2% prior year. Free cash flow was $3.81 billion, or 17.1% margin, supporting dividends and buybacks relevant for income-focused US shareholders.

Industry trends and competitive position

In the household products sector, Procter & Gamble holds a leading position against peers like Colgate-Palmolive and Unilever. Q1 sector review showed strong performance overall, with Procter & Gamble's stable revenue underscoring resilience, per Barchart as of May 2026.

Why Procter & Gamble matters for US investors

Listed on NYSE, Procter & Gamble offers US investors exposure to essential consumer staples with global reach but strong domestic sales. Its dividend aristocrat status and balance sheet—$12.31 billion cash, $37.03 billion debt—provide stability in volatile markets.

Conclusion

Procter & Gamble's Q4 results showed revenue alignment with expectations and an EPS beat, though volume softness and post-earnings dip highlight challenges. Reiterated guidance signals management confidence, while its defensive profile remains appealing for US investors tracking consumer staples amid economic shifts. Market reactions will depend on volume recovery and sector dynamics.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.